The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

Patients with uveitis had a higher risk for psoriatic arthritis and psoriasis, whereas those with psoriatic arthritis had a higher risk for uveitis.

Discover how simple lifestyle changes — like exercise, diet, and better sleep — can help reduce symptoms and improve quality ...

In this video, Raj Chovatiya, MD, PhD, discusses the latest findings on the use of topical roflumilast in patients with ...

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

Have outer foot pain? Here are common causes of pain on the outer side of your foot, the symptoms to watch for, and how to ...

About 1 in 3 people with psoriasis who achieved clear skin with biologic drugs still had underlying inflammation that may ...

A 50-year-old woman, A, recently woke up in the morning and felt a sharp pain in her heels every time she took her first step ...

A lot of people are upset that the Eagles don’t have back-to-back home games and that is by far the biggest quirk in the team’s schedule. They are the only team in the NFL that doesn’t have ...